Approval · Notice of Compliance 14972 · 2013
CONSTELLA: Notice of Compliance 14972
Issued December 2, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14972
- Date
- December 2, 2013
- Company
- Forest Laboratories Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Guanylate cyclase-c agonist
Products in this notice
Medicinal ingredients
- LINACLOTIDE 145 MCG per CAP
- LINACLOTIDE 290 MCG per CAP